The National Institutes of Health on Tuesday reapproved a handful of popular embryonic stem cell lines owned by WiCell, a nonprofit research institute and private support organization of UW-Madison that advances stem cell science.
This means these lines can once again be used in studies backed with federal research dollars.
This is big news to stem cell researchers, who have been expressing frustration with President Barack Obamaâ??s new stem cell policy because it had been creating new barriers and jeopardizing years of experimentation.